| | | Single nucleotide variant (3 prime UTR variant +1 more) | Cardiofaciocutaneous syndrome 3 +1 more | |
| | MAP2K1, SNAPC5 (H341R +1 more) | Single nucleotide variant (3 prime UTR variant +2 more) | Cardiofaciocutaneous syndrome 3 +1 more | |
| | | Single nucleotide variant (3 prime UTR variant +2 more) | Cardiofaciocutaneous syndrome 3 +1 more | |
| | | Single nucleotide variant (missense variant) | Melorheostosis +1 more | |
| | | Single nucleotide variant (splice donor variant) | Melorheostosis +1 more | |
| | | Single nucleotide variant (synonymous variant) | Melorheostosis +1 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | Melorheostosis +1 more | |
| | | Single nucleotide variant (intron variant) | Melorheostosis +1 more | |
| | | Single nucleotide variant (missense variant) | Melorheostosis +1 more | |
| | | Single nucleotide variant (missense variant) | Melorheostosis +1 more | |
| | | Single nucleotide variant (missense variant) | Melorheostosis +1 more | |
| | | Single nucleotide variant (intron variant) | Melorheostosis +1 more | |
| | | Single nucleotide variant (5 prime UTR variant) | Melorheostosis +1 more | |
| | | Single nucleotide variant (3 prime UTR variant +2 more) | Cardiovascular phenotype | |
| | | Single nucleotide variant (3 prime UTR variant +2 more) | Cardiovascular phenotype | |
| | MAP2K1, SNAPC5 (S337fs +1 more) | Deletion (3 prime UTR variant +2 more) | Cardiovascular phenotype | |
| | | Duplication (3 prime UTR variant +3 more) | not provided | |
| | MAP2K1, SNAPC5 (S316Y +1 more) | Single nucleotide variant (3 prime UTR variant +2 more) | Cardiovascular phenotype | |
| | | Duplication | RASopathy | |
| | | Duplication | RASopathy | |
| | | Single nucleotide variant (missense variant) | Cardiofaciocutaneous syndrome 3 | |
| | MAP2K1, SNAPC5 (F323L +1 more) | Single nucleotide variant (3 prime UTR variant +2 more) | RASopathy | |
| | | Single nucleotide variant (3 prime UTR variant +2 more) | RASopathy | |
| | | Single nucleotide variant (synonymous variant +2 more) | RASopathy | |
| | | Single nucleotide variant (3 prime UTR variant +2 more) | RASopathy | |
| | MAP2K1, SNAPC5 (S337G +1 more) | Single nucleotide variant (3 prime UTR variant +2 more) | RASopathy | |
| | MAP2K1, SNAPC5 (T338I +1 more) | Single nucleotide variant (3 prime UTR variant +2 more) | RASopathy | |
| | | Single nucleotide variant (3 prime UTR variant +2 more) | RASopathy | |
| | MAP2K1, SNAPC5 (D303E +1 more) | Single nucleotide variant (3 prime UTR variant +2 more) | RASopathy | |
| | | Deletion (3 prime UTR variant +2 more) | RASopathy | |
| | | Single nucleotide variant (3 prime UTR variant +2 more) | RASopathy | |
| | | Single nucleotide variant (3 prime UTR variant +2 more) | RASopathy | |
| | MAP2K1, SNAPC5 (L304V +1 more) | Single nucleotide variant (3 prime UTR variant +2 more) | RASopathy | |
| | | Single nucleotide variant (3 prime UTR variant +2 more) | RASopathy | |
| | | Single nucleotide variant (3 prime UTR variant +2 more) | Cardiovascular phenotype +1 more | |
| | | Deletion (inframe_deletion) | Vascular malformation | |
| | | Single nucleotide variant (3 prime UTR variant +1 more) | not provided | |
| | | Indel (3 prime UTR variant +2 more) | not provided | |
| | | Single nucleotide variant (3 prime UTR variant +2 more) | Cardiovascular phenotype | |
| | MAP2K1, SNAPC5 (M308T +1 more) | Single nucleotide variant (3 prime UTR variant +2 more) | Cardiovascular phenotype +1 more | |
| | | Indel (3 prime UTR variant +2 more) | not provided | |
| | MAP2K1, SNAPC5 (S316F +1 more) | Single nucleotide variant (3 prime UTR variant +2 more) | not provided | |
| | MAP2K1, SNAPC5 (N334K +1 more) | Single nucleotide variant (3 prime UTR variant +2 more) | Cardiovascular phenotype | |
| | | Single nucleotide variant (3 prime UTR variant +2 more) | RASopathy | |
| | | Single nucleotide variant (3 prime UTR variant +2 more) | RASopathy | |
| | | Single nucleotide variant (3 prime UTR variant +2 more) | RASopathy | |
| | | Single nucleotide variant (3 prime UTR variant +2 more) | RASopathy | |
| | | Single nucleotide variant (3 prime UTR variant +2 more) | RASopathy | |
| | | Single nucleotide variant (3 prime UTR variant +2 more) | Cardiovascular phenotype | |
| | | Single nucleotide variant (3 prime UTR variant +2 more) | Cardiovascular phenotype | |
| | | Single nucleotide variant (3 prime UTR variant +2 more) | Cardiovascular phenotype +1 more | |
| | | Single nucleotide variant (3 prime UTR variant +2 more) | RASopathy | |
| | | Single nucleotide variant (3 prime UTR variant +2 more) | RASopathy | |
| | | Deletion (3 prime UTR variant +2 more) | RASopathy | |
| | | Single nucleotide variant (3 prime UTR variant +2 more) | RASopathy | |
| | MAP2K1, SNAPC5 (G380S +1 more) | Single nucleotide variant (3 prime UTR variant +2 more) | Noonan syndrome and Noonan-related syndrome +1 more | |
| | MAP2K1, SNAPC5 (S377F +1 more) | Single nucleotide variant (3 prime UTR variant +2 more) | Noonan syndrome and Noonan-related syndrome +1 more | |
| | MAP2K1, SNAPC5 (A372V +1 more) | Single nucleotide variant (3 prime UTR variant +2 more) | RASopathy +1 more | |
| | | Single nucleotide variant (5 prime UTR variant) | not provided | |
| | | Single nucleotide variant (3 prime UTR variant +2 more) | not provided | |
| | | Single nucleotide variant (5 prime UTR variant) | not provided | |
| | | Single nucleotide variant (3 prime UTR variant +1 more) | not provided | |
| | | Single nucleotide variant (3 prime UTR variant +1 more) | not provided | |
| | | Single nucleotide variant (3 prime UTR variant +2 more) | not provided | |
| | | Single nucleotide variant (3 prime UTR variant +2 more) | not provided | |
| | MAP2K1, SNAPC5 (V393I +1 more) | Single nucleotide variant (3 prime UTR variant +2 more) | Melorheostosis +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (3 prime UTR variant +2 more) | not provided | |
| | | Duplication (5 prime UTR variant) | not provided | |
| | | Single nucleotide variant (3 prime UTR variant +2 more) | Cardiovascular phenotype +2 more | |
| | | Duplication (3 prime UTR variant +3 more) | RASopathy | |
| | | Single nucleotide variant (3 prime UTR variant +2 more) | not specified +2 more | |
| | | Single nucleotide variant (3 prime UTR variant +2 more) | not specified +1 more | |
| | MAP2K1, SNAPC5 (H358Y +1 more) | Single nucleotide variant (3 prime UTR variant +2 more) | RASopathy | |
| | | Single nucleotide variant (missense variant) | Noonan syndrome | |
| | | Single nucleotide variant (missense variant) | Noonan syndrome | |
| | | Single nucleotide variant (missense variant) | Noonan syndrome | |
| | | Single nucleotide variant (missense variant) | Cardio-facio-cutaneous syndrome | |
| | MAP2K1, SNAPC5 (I379V +1 more) | Single nucleotide variant (3 prime UTR variant +2 more) | RASopathy +3 more | |
| | | Deletion (3 prime UTR variant +3 more) | RASopathy | |
| | | Deletion (frameshift variant) | not provided | |
| | | Single nucleotide variant (3 prime UTR variant +2 more) | not provided | |
| | MAP2K1, SNAPC5 (L375I +1 more) | Single nucleotide variant (3 prime UTR variant +2 more) | not specified +2 more | |
| | | Single nucleotide variant (3 prime UTR variant +2 more) | RASopathy | |
| | | Single nucleotide variant (3 prime UTR variant +2 more) | not specified +2 more | GConflicting classifications of pathogenicity |
| | MAP2K1, SNAPC5 (M356V +1 more) | Single nucleotide variant (3 prime UTR variant +2 more) | not specified +2 more | |
| | MAP2K1, SNAPC5 (A391V +1 more) | Single nucleotide variant (3 prime UTR variant +2 more) | Cardiovascular phenotype +2 more | GConflicting classifications of pathogenicity |
| | | Deletion (3 prime UTR variant +1 more) | Noonan syndrome +1 more | |
| | | Duplication (3 prime UTR variant +1 more) | Noonan syndrome +2 more | GConflicting classifications of pathogenicity |
| | | Deletion (3 prime UTR variant +1 more) | Noonan syndrome +1 more | |
| | | Microsatellite (5 prime UTR variant) | Cardio-facio-cutaneous syndrome +2 more | |
| | MAP2K1, SNAPC5 (A390T +1 more) | Single nucleotide variant (3 prime UTR variant +2 more) | not provided +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (3 prime UTR variant +2 more) | RASopathy | |
| | | Microsatellite (3 prime UTR variant +2 more) | RASopathy | |
| | | Single nucleotide variant (3 prime UTR variant +2 more) | RASopathy | |
| | MAP2K1, SNAPC5 (Q354H +1 more) | Single nucleotide variant (3 prime UTR variant +2 more) | RASopathy +2 more | |
| | | Duplication | not specified | |